2.4.0.6 Html 253 367 1 false 77 0 false 5 false false R1.htm 0000 - Document - Document and Entity Information Sheet http://www.amagpharma.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 0010 - Statement - Consolidated Balance Sheets Sheet http://www.amagpharma.com/role/BalanceSheet Consolidated Balance Sheets false false R3.htm 0015 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.amagpharma.com/role/BalanceSheetParenthetical Consolidated Balance Sheets (Parenthetical) false false R4.htm 0020 - Statement - Consolidated Statements of Operations Sheet http://www.amagpharma.com/role/StatementOfIncome Consolidated Statements of Operations false false R5.htm 0030 - Statement - Consolidated Statements of Comprehensive Loss Sheet http://www.amagpharma.com/role/StatementOfComprehensiveLoss Consolidated Statements of Comprehensive Loss false false R6.htm 0040 - Statement - Consolidated Statements of Stockholders' Equity Sheet http://www.amagpharma.com/role/StatementOfStockholdersEquity Consolidated Statements of Stockholders' Equity false false R7.htm 0045 - Statement - Consolidated Statements of Stockholders' Equity (Parenthetical) Sheet http://www.amagpharma.com/role/StatementOfStockholdersEquityParenthetical Consolidated Statements of Stockholders' Equity (Parenthetical) false false R8.htm 0050 - Statement - Consolidated Statements of Cash Flows Sheet http://www.amagpharma.com/role/CashFlows Consolidated Statements of Cash Flows false false R9.htm 1010 - Disclosure - Description of Business Sheet http://www.amagpharma.com/role/DisclosureDescriptionOfBusiness Description of Business false false R10.htm 1020 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.amagpharma.com/role/DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies false false R11.htm 1030 - Disclosure - Investments Sheet http://www.amagpharma.com/role/DisclosureInvestments Investments false false R12.htm 1040 - Disclosure - Accounts Receivable, Net Sheet http://www.amagpharma.com/role/DisclosureAccountsReceivableNet Accounts Receivable, Net false false R13.htm 1050 - Disclosure - Inventories Sheet http://www.amagpharma.com/role/DisclosureInventories Inventories false false R14.htm 1060 - Disclosure - Property, Plant and Equipment, Net Sheet http://www.amagpharma.com/role/DisclosurePropertyPlantAndEquipmentNet Property, Plant and Equipment, Net false false R15.htm 1070 - Disclosure - Current and Long-Term Liabilities Sheet http://www.amagpharma.com/role/DisclosureCurrentAndLongTermLiabilities Current and Long-Term Liabilities false false R16.htm 1080 - Disclosure - Income Taxes Sheet http://www.amagpharma.com/role/DisclosureIncomeTaxes Income Taxes false false R17.htm 1090 - Disclosure - Equity-Based Compensation Sheet http://www.amagpharma.com/role/DisclosureEquityBasedCompensation Equity-Based Compensation false false R18.htm 1100 - Disclosure - Employee Savings Plan Sheet http://www.amagpharma.com/role/DisclosureEmployeeSavingsPlan Employee Savings Plan false false R19.htm 1110 - Disclosure - Stockholders' Equity Sheet http://www.amagpharma.com/role/DisclosureStockholdersEquity Stockholders' Equity false false R20.htm 1120 - Disclosure - Business Segments Sheet http://www.amagpharma.com/role/DisclosureBusinessSegments Business Segments false false R21.htm 1130 - Disclosure - Commitments and Contingencies Sheet http://www.amagpharma.com/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies false false R22.htm 1140 - Disclosure - Collaborative Agreements Sheet http://www.amagpharma.com/role/DisclosureCollaborativeAgreements Collaborative Agreements false false R23.htm 1150 - Disclosure - Restructuring Sheet http://www.amagpharma.com/role/DisclosureRestructuring Restructuring false false R24.htm 1160 - Disclosure - Consolidated Quarterly Financial Data-Unaudited Sheet http://www.amagpharma.com/role/DisclosureConsolidatedQuarterlyFinancialData Consolidated Quarterly Financial Data-Unaudited false false R25.htm 1170 - Disclosure - Valuation and Qualifying Accounts Sheet http://www.amagpharma.com/role/DisclosureValuationAndQualifyingAccounts Valuation and Qualifying Accounts false false R26.htm 1180 - Disclosure - Recently Issued and Proposed Accounting Pronouncements Sheet http://www.amagpharma.com/role/DisclosureRecentlyIssuedAndProposedAccountingPronouncements Recently Issued and Proposed Accounting Pronouncements false false R27.htm 2020 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.amagpharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) false false R28.htm 3020 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.amagpharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) false false R29.htm 3030 - Disclosure - Investments (Tables) Sheet http://www.amagpharma.com/role/DisclosureInvestmentsTables Investments (Tables) false false R30.htm 3040 - Disclosure - Accounts Receivable, Net (Tables) Sheet http://www.amagpharma.com/role/DisclosureAccountsReceivableNetTables Accounts Receivable, Net (Tables) false false R31.htm 3050 - Disclosure - Inventories (Tables) Sheet http://www.amagpharma.com/role/DisclosureInventoriesTables Inventories (Tables) false false R32.htm 3060 - Disclosure - Property, Plant and Equipment, Net (Tables) Sheet http://www.amagpharma.com/role/DisclosurePropertyPlantAndEquipmentNetTables Property, Plant and Equipment, Net (Tables) false false R33.htm 3070 - Disclosure - Current and Long-Term Liabilities (Tables) Sheet http://www.amagpharma.com/role/DisclosureCurrentAndLongTermLiabilitiesTables Current and Long-Term Liabilities (Tables) false false R34.htm 3080 - Disclosure - Income Taxes (Tables) Sheet http://www.amagpharma.com/role/DisclosureIncomeTaxesTables Income Taxes (Tables) false false R35.htm 3090 - Disclosure - Equity-Based Compensation (Tables) Sheet http://www.amagpharma.com/role/DisclosureEquityBasedCompensationTables Equity-Based Compensation (Tables) false false R36.htm 3130 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.amagpharma.com/role/DisclosureCommitmentsAndContingenciesTables Commitments and Contingencies (Tables) false false R37.htm 3150 - Disclosure - Restructuring (Tables) Sheet http://www.amagpharma.com/role/DisclosureRestructuringTables Restructuring (Tables) false false R38.htm 3160 - Disclosure - Consolidated Quarterly Financial Data-Unaudited (Tables) Sheet http://www.amagpharma.com/role/DisclosureConsolidatedQuarterlyFinancialDataTables Consolidated Quarterly Financial Data-Unaudited (Tables) false false R39.htm 3170 - Disclosure - Valuation and Qualifying Accounts (Tables) Sheet http://www.amagpharma.com/role/DisclosureValuationAndQualifyingAccountsTables Valuation and Qualifying Accounts (Tables) false false R40.htm 4010 - Disclosure - Description of Business (Details) Sheet http://www.amagpharma.com/role/DisclosureDescriptionOfBusinessDetails Description of Business (Details) false false R41.htm 4020 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://www.amagpharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) false false R42.htm 4021 - Disclosure - Summary of Significant Accounting Policies (Details 2) Sheet http://www.amagpharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails2 Summary of Significant Accounting Policies (Details 2) false false R43.htm 4022 - Disclosure - Summary of Significant Accounting Policies (Details 3) Sheet http://www.amagpharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails3 Summary of Significant Accounting Policies (Details 3) false false R44.htm 4023 - Disclosure - Summary of Significant Accounting Policies (Details 4) Sheet http://www.amagpharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails4 Summary of Significant Accounting Policies (Details 4) false false R45.htm 4024 - Disclosure - Summary of Significant Accounting Policies (Details 5) Sheet http://www.amagpharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails5 Summary of Significant Accounting Policies (Details 5) false false R46.htm 4030 - Disclosure - Investments (Details) Sheet http://www.amagpharma.com/role/DisclosureInvestmentsDetails Investments (Details) false false R47.htm 4031 - Disclosure - Investments (Details 2) Sheet http://www.amagpharma.com/role/DisclosureInvestmentsDetails2 Investments (Details 2) false false R48.htm 4040 - Disclosure - Accounts Receivable, Net (Details) Sheet http://www.amagpharma.com/role/DisclosureAccountsReceivableNetDetails Accounts Receivable, Net (Details) false false R49.htm 4050 - Disclosure - Inventories (Details) Sheet http://www.amagpharma.com/role/DisclosureInventoriesDetails Inventories (Details) false false R50.htm 4060 - Disclosure - Property, Plant and Equipment, Net (Details) Sheet http://www.amagpharma.com/role/DisclosurePropertyPlantAndEquipmentNetDetails Property, Plant and Equipment, Net (Details) false false R51.htm 4070 - Disclosure - Current and Long-Term Liabilities (Details) Sheet http://www.amagpharma.com/role/DisclosureCurrentAndLongTermLiabilitiesDetails Current and Long-Term Liabilities (Details) false false R52.htm 4080 - Disclosure - Income Taxes (Details) Sheet http://www.amagpharma.com/role/DisclosureIncomeTaxesDetails Income Taxes (Details) false false R53.htm 4081 - Disclosure - Income Taxes (Details 2) Sheet http://www.amagpharma.com/role/DisclosureIncomeTaxesDetails2 Income Taxes (Details 2) false false R54.htm 4090 - Disclosure - Equity-Based Compensation (Details) Sheet http://www.amagpharma.com/role/DisclosureEquityBasedCompensationDetails Equity-Based Compensation (Details) false false R55.htm 4091 - Disclosure - Equity-Based Compensation (Details 2) Sheet http://www.amagpharma.com/role/DisclosureEquityBasedCompensationDetails2 Equity-Based Compensation (Details 2) false false R56.htm 4092 - Disclosure - Equity-Based Compensation (Details 3) Sheet http://www.amagpharma.com/role/DisclosureEquityBasedCompensationDetails3 Equity-Based Compensation (Details 3) false false R57.htm 4093 - Disclosure - Equity-Based Compensation (Details 4) Sheet http://www.amagpharma.com/role/DisclosureEquityBasedCompensationDetails4 Equity-Based Compensation (Details 4) false false R58.htm 4094 - Disclosure - Equity-Based Compensation (Details 5) Sheet http://www.amagpharma.com/role/DisclosureEquityBasedCompensationDetails5 Equity-Based Compensation (Details 5) false false R59.htm 4100 - Disclosure - Employee Savings Plan (Details) Sheet http://www.amagpharma.com/role/DisclosureEmployeeSavingsPlanDetails Employee Savings Plan (Details) false false R60.htm 4110 - Disclosure - Stockholders' Equity (Details) Sheet http://www.amagpharma.com/role/DisclosureStockholdersEquityDetails Stockholders' Equity (Details) false false R61.htm 4120 - Disclosure - Business Segments (Details) Sheet http://www.amagpharma.com/role/DisclosureBusinessSegmentsDetails Business Segments (Details) false false R62.htm 4130 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.amagpharma.com/role/DisclosureCommitmentsAndContingenciesDetails Commitments and Contingencies (Details) false false R63.htm 4140 - Disclosure - Collaborative Agreements (Details) Sheet http://www.amagpharma.com/role/DisclosureCollaborativeAgreementsDetails Collaborative Agreements (Details) false false R64.htm 4150 - Disclosure - Restructuring (Details) Sheet http://www.amagpharma.com/role/DisclosureRestructuringDetails Restructuring (Details) false false R65.htm 4160 - Disclosure - Consolidated Quarterly Financial Data-Unaudited (Details) Sheet http://www.amagpharma.com/role/DisclosureConsolidatedQuarterlyFinancialDataDetails Consolidated Quarterly Financial Data-Unaudited (Details) false false R66.htm 4170 - Disclosure - Valuation and Qualifying Accounts (Details) Sheet http://www.amagpharma.com/role/DisclosureValuationAndQualifyingAccountsDetails Valuation and Qualifying Accounts (Details) false false All Reports Book All Reports Element us-gaap_MarketableSecuritiesGainLoss had a mix of decimals attribute values: -5 -3. Element us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent had a mix of decimals attribute values: -5 -3. Element us-gaap_RestructuringCharges had a mix of decimals attribute values: -5 -3. Element us-gaap_StockIssuedDuringPeriodValueNewIssues had a mix of decimals attribute values: -5 -3. 'Monetary' elements on report '4020 - Disclosure - Summary of Significant Accounting Policies (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '4021 - Disclosure - Summary of Significant Accounting Policies (Details 2)' had a mix of different decimal attribute values. 'Monetary' elements on report '4022 - Disclosure - Summary of Significant Accounting Policies (Details 3)' had a mix of different decimal attribute values. 'Monetary' elements on report '4023 - Disclosure - Summary of Significant Accounting Policies (Details 4)' had a mix of different decimal attribute values. 'Monetary' elements on report '4031 - Disclosure - Investments (Details 2)' had a mix of different decimal attribute values. 'Monetary' elements on report '4050 - Disclosure - Inventories (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '4070 - Disclosure - Current and Long-Term Liabilities (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '4080 - Disclosure - Income Taxes (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '4110 - Disclosure - Stockholders' Equity (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '4130 - Disclosure - Commitments and Contingencies (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '4160 - Disclosure - Consolidated Quarterly Financial Data-Unaudited (Details)' had a mix of different decimal attribute values. Process Flow-Through: 0010 - Statement - Consolidated Balance Sheets Process Flow-Through: Removing column 'Dec. 31, 2010' Process Flow-Through: Removing column 'Dec. 31, 2009' Process Flow-Through: 0015 - Statement - Consolidated Balance Sheets (Parenthetical) Process Flow-Through: Removing column 'Jan. 30, 2010' Process Flow-Through: 0020 - Statement - Consolidated Statements of Operations Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2012' Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2012' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2012' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2012' Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2011' Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2011' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2011' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2011' Process Flow-Through: 0030 - Statement - Consolidated Statements of Comprehensive Loss Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2012' Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2012' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2012' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2012' Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2011' Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2011' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2011' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2011' Process Flow-Through: 0045 - Statement - Consolidated Statements of Stockholders' Equity (Parenthetical) Process Flow-Through: 0050 - Statement - Consolidated Statements of Cash Flows amag-20121231.xml amag-20121231.xsd amag-20121231_cal.xml amag-20121231_def.xml amag-20121231_lab.xml amag-20121231_pre.xml true true